Trial
NCT00108485
Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
Extended release niacin
Why stopped
Unable to recruit sufficient study subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-22